In July 2012, Cybereason was founded and incorporated in Delaware, United States.[2]
In 2014, Cybereason established its headquarters in Boston, Massachusetts.[3]
In August 2016, Cybereason incorporated a subsidiary in the United Kingdom.
In June 2017, Cybereason launched Malicious Life, a podcast about the history of cybersecurity.[4][non-primary source needed]
In 2017, Cybereason established an office in London, England.
Funding
In 2014, Cybereason raised Series A funding from Charles River Ventures.[5] In total, Cybereason reports having raised $88.6M in funding rounds, receiving $59M in its Series C round from Softbank in 2015.
.[6]
In August 2019, Cybereason raised $200 million in new financing from SoftBank Group and its affiliates.[7]
In April 2023, Cybereason raised an additional $100 million in venture funding from SoftBank Group and appointed SoftBank’s executive vice president, Eric Gan, as its new CEO, resulting in more than 50 percent ownership by SoftBank Group and SoftBank Venture Fund.[8]
Nocturnus is Cybereason's security research arm. The Nocturnus team specializes in discovering new attack methodologies, reverse-engineering malware, and exposing new system vulnerabilities. Nocturnus was the first to discover a vaccination for the 2017 NotPetya and Bad Rabbit cyberattacks.[11][12]
